CLINICAL_TRIALS
trial_result
· 2012-09-25
Clinical Trial Update: Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin [Phase 2, Phase 3]
Summary
This update reports results from Phase 2 and Phase 3 trials evaluating pharmacogenetic algorithms to tailor warfarin dosing for thromboembolism.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Intermountain Health Care, Inc. | Conditions: Thromboembolism | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-09-25